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Abstract 
CONTEXT: Sharing and exploiting efficiently Health Big Data 
(HBD) lead to tackle great challenges: data protection and 
governance taking into account legal, ethical and 
deontological aspects which enables a trust, transparent and 
win-to-win relationship between researchers, citizen and data 
providers. Lack of interoperability: data are 
compartmentalized and are so syntactically and semantically 
heterogeneous. Variable data quality with a great impact on 
data management and statistical analysis. The objective of the 
INSHARE project is to explore, through an experimental proof 
of concept, how recent technologies could overcome such 
issues. It aims at demonstrating the feasibility and the added 
value of an IT platform based on CDW, dedicated to 
collaborative HBD sharing for medical research. METHOD: 
The consortium includes 6 data providers: 2 academic 
hospitals, the SNIIRAM (the French national reimbursement 
database) and 3 national or regional registries. The platform is 
designed following a 3 steps approach: (1) to analyze use cases, 
needs and requirements (2). To define data sharing governance 
and secure access to the platform, (3) To define the platform 
specifications. RESULT: 3 use cases (healthcare trajectory 
analysis, epidemiologic registry enrichment, signal detection) 
were analyzed to design the platform. corresponding to 5 
studies and using 11 data sources. The governance was derived 
from the SCANNER model and adapted to data sharing. As a 
result, the platform architecture integrates the following tools 
and services: Data repository and hosting, semantic 
integration services, data processing, aggregate computing, 
data quality and integrity monitoring, Id linking, Multisource 
query builder, Visualization and data export services, data 
governance, study management service and security including 
data watermarking.. 
Keywords: Data sharing, Information Storage and Retrieval, 
Registries/statistics & numerical data 
Introduction 
In its broad definition, Health Big Data (HBD) is more than just 
a very large amount of data or a large number of data sources. 
It also refers to the complexity, the challenges and the new 
opportunities presented by the combined analysis of data. 
Health data collected or produced are now potentially sharable 
and reusable. They can be exploited at different levels and 
across different domains, especially concerning questions 
related to multidisciplinary research. This huge amount of data 
holds the promise of supporting a wide range of medical and 
health care functions, including among others clinical decision 
support, disease surveillance or population health management 
[1]. This explains the incentive policy of opening HBD around 
health data science being supported by different public 
authorities and scientific communities such as OpenData, 
AVIESAN  or Inserm initiatives, as well as European research 
programs like IMI or Horizon 2020. Recently, strong initiatives 
have been launched in the U.S to enhance the utility of health 
Big Data and finally to enter in the next level of knowledge 
discovery [2].   
In this context, clinical data warehouse (CDW) technology 
comes forward as one of the solutions to address HBD 
exploitation. CDW, which are becoming increasingly 
widespread in the US, are being put to use for different purposes 
such as cohort discovery, biomarker detection, feasibility 
studies or the enrolment of patients in clinical trials. Research 
communities are currently connecting CDW to one another 
with the aim of creating Clinical Data Research Networks (e.g. 
PCORNET [2]) or biomedical research network (e.g. Data to 
Knowledge).  
In these networks, data providers such as researchers, health 
facilities, research agencies or institutions provide a part of their 
data available to the research community while maintaining 
data-sharing control at all time. Thus, these trusted third-party 
platforms integrate and open-up scientific or potentially 
scientific health data [3]. This makes the use of these data at a 
large-scale possible. In France, such a platform, that would be 
able to integrate and share multisource and multiscale big and 
small health data produced by health institutions for research 
purposes, does not exist.   
This is the aim of the INSHARE French national project; 
project in which different and very actual key issues like the 
governance as well as the organizational and technical factors 
to perform a such data sharing will be explored and addressed. 
The absolute goal is to facilitate access to data and to foster 
collaborative research and data sharing between researchers 
and data providers. In this paper, we present and discuss these 
key issues as well as the approach we are following so as to 
design the platform; approach driven by real research use cases 
of high interest for individuals as well as for states.In this paper, 
we present and discuss these key issues as well as the approach 
we are following so as to design the platform; approach driven 
by real research use cases of high interest for individuals as well 
as for states.  
 
Background 
The data to share: In its large acceptance HBD sources 
comprise various types of data from structured information 
such as OMICS data, administrative or billing data, drug 
prescription data consisting of dates and dosages that are 
captured through a standardized ePrescription system, to 
unstructured and textual data such as clinical narratives that 
describe the medical reasoning behind prescriptions [4]. 
Beyond the data generated by hospitals, several health data 
sources come from health registries or insurance databases, 
which are a valuable source of standardized, longitudinal, 
population-wide data. For instance, the French health 
reimbursement database (Système National d’Information 
Inter-Régimes de l’Assurance Maladie, SNIIR- AM) contains 
individualized, anonymous and comprehensive data for all 
health spending reimbursements received by affiliated subjects, 
including basic patient demographic data such as age, gender 
and medical drugs, as well as outpatient medical cares, 
prescribed or performed by health professionals from both 
public and private practices. The SNIIR-AM is also linked via 
a unique personal health number to the French hospital 
discharge database (PMSI), which contains diagnostic codes, 
medical procedures and admission dates for all hospitalizations. 
Data from the SNIIR-AM is increasingly used for research 
projects, especially relation to the detection of drugs’ adverse 
effects  in epidemiology or in clinical research. The platform 
governance models was designed derived from the SCANNER 
model and adapted to the data sharing.   
The sharing barriers: The regulatory hurdles obstructing 
optimal use of data for research have been extensively 
discussed within specialised literature [5]. The identified 
factors are characterized by (i) an over-cautious approach 
among data custodians, many of whom are unwilling to link or 
share data, (ii) legislators’ failure to consider the flexibility 
required to allow and support such linking and sharing and (iii) 
the incorporation of ‘good governance’ models or intelligent 
design of working instances thereof are not contemplated 
within the regulatory framework, nor is there any reflection on 
the subject [5], [6]. Sethi proposes a model for data- sharing 
governance including (i) guiding principles and best practices, 
(ii) safe, effective and proportionate governance, (iii) an 
articulation of the roles and responsibilities of data controllers 
and data processors and (iv) the development of a training 
program for researchers that covers appropriate vetting 
procedures prior to sharing valuable data .   
The cornerstone of data sharing and reuse is trust. 
Therefore, implementing a trustworthy process for handling 
citizens’ and patients’ health data is a pivotal goal. Based on the 
definition of, in a trusted relationship, one party (trustor) is 
willing to rely on the actions of another party. In addition, the 
trustor abandons (full) control over the actions performed by 
the trustee. As a consequence, a trustworthy system is that in 
which the trustor can “place his/her trust and rest assured that 
the trust will not be betrayed”. A system for data reuse should 
thus prove its trustworthiness by fulfilling the responsibility of 
dealing with data within the limits of a social contract regulated 
by policies between citizens and the organizations handling the 
system.  
The technological components behind a trustworthy system 
involve designing and implementing IT tools and services 
capable of guaranteeing data quality and security while 
providing interoperability, adaptability and scalability. Specific 
projects funded by the EU and by the IMI initiative [7], such as 
EHR4CR, are dealing with such challenges, with the prospect 
of defining use cases, tools, technologies and a business model 
for data reuse. In particular, the EHR4CR business model 
includes accreditation and certification plans for EHR systems 
that can be integrated within a system for data reuse. The 
purpose of data reuse has implications that belong to the realm 
of policies and regulations, which are essential aspects for 
establishing trust. How to manage informed consent is one of 
the key aspects connected to this issue. In fact, the current 
regulations in many European countries, which are similar to 
the US, with the HIPAA act, assume that consent (implied or 
explicit) for use of data is strictly limited to the purpose for 
which data were collected. This may seriously limit the scope 
of data analysis.   
This theme needs to be reconsidered in the light of the existence 
of a proper, trustworthy system based on an agreement between 
citizens and healthcare organizations. Specific practical 
examples of policies for handling data reuse are provided by 
regional initiatives in Europe, two such cases being the United 
Kingdom and Catalonia. ISO/TS 14265:2011 provides a 
classification of different purposes for processing personal 
health information that can help make policy formulation more 
granular. 
Methods 
To design the organizational and technical dimension of the 
INSHARE platform, an iterative and 4 steps bottom-to-top 
approach has been adopted, by analyzing on the ground, 
existing needs, use cases and actual difficulties encountered by 
the project partners. Four partners are involved in the project as 
data providers: 2 academic hospitals (CHU Rennes and Brest) 
which provide datamarts from their Clinical Data Warehouse 
(eHOP-CDW), 3 epidemiologic registries at a regional or 
national scale. 
This approach aims at defining technical and functional 
specifications, data protection policies and governance for an 
efficient and valuable data sharing. Furthermore, this approach 
takes into account the fact that some technological issues have 
to be addressed and especially the evolution needs for data 
analysis and security tools in the scaling-up to HBD.  
Step 1 - To Describe use cases and user needs: The aim of 
this step is to define precisely scenarios from an operational 
perspective, the information workflow and the system/actor 
interfaces that relate to the exploitation of health and research 
data via the INSHARE platform. The relevant scenarios 
leverage the richness and the variability of the data sources 
hosted by the platform in terms of domain, quality and origin. 
Herein, the objective is to identify the functional needs, which 
are expected by the different users of the platform: researchers-
users, data providers as well as the internal operators of the 
platform.  
Step 2 - To define data sharing governance and secure 
access to the platform: Regarding the ethical, legal and 
deontological aspects, a focus group composed of domain 
experts and representatives of patient associations conducts this 
study. According to the state-of-the-art step and the specified 
use cases defined at the first step, the objective is to establish 
governance guidelines guaranteeing data protection and 
individuals’ privacy rights. This step includes the submission 
of these guidelines for validation to institutional and regulatory 
authorities such as the Comité consultatif sur le traitement de 
l'information en matière de recherche (CCTIRS) and the 
Commission Nationale de l'Informatique et des Libertés 
(CNIL), two French authorities in charge of such regulation 
aspect.  
Step 3 - To define INSHARE platform specifications: The 
aim of this step is to define a comprehensive description of the 
intended purpose and environment of the platform. These 
specification describe what the software does and how it will 
be expected to perform, taking into accounts the operational 
scenarios, security aspects and the stakeholders (users, data 
providers, and data managers) inputs. It also addresses some 
key issues in relation with data analysis and security. In terms 
of data protection in the scaling up, a special interest is given to 
the data traceability and on how to give back some control to 
data providers on the data they make available to researchers. 
On one hand, users have to know of their action accountability 
and, in another hand, patient or data provider consent for data 
exploitation duration has to be guaranteed. Database 
watermarking, a very recent solution [8], is one of the 
technology actually explored for those purposes.    
Each data provider is part of the INSHARE project to bring 
their knowledge and experience with their respective data. Data 
providers are thus responsible for supplying necessary data to 
the platform in order to answer to the use cases. They have to 
supply as well all necessary information about data to correctly 
perform their integration and to subsequently give the 
capability to the platform to provide the best-suited data for 
each user request.   
 Results  
Use Cases: Three main use cases corresponding to 5 studies 
and application domains have been identified and chosen to be 
performed on the platform. Being able to ensure one of them 
will be of great interest for cares of individuals as well as for 
populations. Table 1 illustrates for each use case the sources of 
data which will be shared and used in the different INSHARE 
platform studies.  
Table 1 : Use cases and application domain 
For instance, regarding the study on health care trajectories of 
end-stage renal disease patients, comorbidities are currently 
collected and registered in the REIN database at the initiation 
of the renal replacement therapy (RRT) . But the occurrence of 
comorbidities after RRT started is not a mandatory field of 
REIN [9]. Moreover, no information on prescribed treatments 
is available in the REIN database. Through the INSHARE 
platform, the hospital CDW (Rennes and Brest) will be used to 
collect comorbidities and expensive drug prescriptions while 
drug exposures will be extracted from SNIIR-AM in order to 
enrich the REIN registry with accurate comorbidities and 
medications including standards and dates of occurrence. 
Table 1: Uses case under the scope of the Inshare Platform 
 
Platform governance: The governance determines how the 
range of controls and procedures with contractual obligations 
work together so as to ensure an end-to-end secure and 
trustfully platform, where the security and reliability of data is 
guaranteed. Indeed, several. INSHARE use cases imply to 
perform Id linkage processing and require the access to 
identified data (e.g., Epidemiologic registry enrichment). 
Moreover, all use cases require to aggregate data coming from 
multiscale institutions (local academic hospitals, regional to 
national registries, and for the SNIIR-AM, data issued from a 
nationwide database). Some of them imply intensive 
computation on big volume of data (e.g signal detection). All 
these constraints have led to define a model of governance for 
the platform adapted to big data sharing. The model we propose 
is derived and adapted from the Distributed Scalable National 
Network for Effectiveness Research (SCANNER). It consists 
in the identification of 10 basic requirements: platform and data 
provider information, institution information, study 
information, ethical agreements (coming from an independent 
IRB-like comity), Data Sharing Agreement (from data 
providers who are involved in the study), approved users 
(external users and internal operators of the platform), 
authentication and access, data use, audit and accounting, 
patient rights, data segregation). In addition, according to the 
type of personal data, it includes de-identification, data 
watermarking, individual access, correction, 
openness/transparency, individual choice, use and disclosure 
limitation, integrity, accountability, safeguards. Some 
requirements can be met by technology and some others by 
contracts, attestation of users, or management supervision. 
Platform Design: As a result, we designed the platform 
architecture shown in figure 1. This architecture is oriented to 
meet the different use cases under the scope of the project, and 
to perform the expected data processing while respecting the 
governance framework mentioned above. The platform 
encompasses services of several weakly coupled components, 
the whole in a cloud oriented architecture. Hereby, we detail 
some of the key components and services: 
The data repository and hosting component is a buffer zone 
where data providers make available the required datasets or 
datamart to share. The core idea is to host in the platform data 
Use case  Study & application  domain  Data sources  
Health care   
Trajectory  
analysis  
Pre and post-dialysis care 
trajectory of end-stage renal 
disease patients starting dia-
lysis in emergency  
  
Characterizing the 
healthcare trajectories of 
children (and their mother) 
included in Birth Defect 
Registry   
Kidney Failure 
registry (REIN)  
  
SNIIR-AM  
  
Birth defect   
registry  
  
eHOP-CDW  
Registry  
enrichment  
Assessment of association 
between cancer incidence 
and diabetes in end-stage 
renal disease patients  
Kidney Failure 
registry (REIN) 
Cancer registry  
SNIIR-AM  
Signal   
detection  
Influenza surveillance  
  
Adverse drug effect surveil-
lance  
eHOP-CDW  
SNIIR-AM  
Sentinel Net-
work Open 
Data  
with the finest granularity and in their most original form, i.e., 
with the less transformation possible.   
The health big data integration layer comprises the 
components and services dedicated to data integration and 
processing. The semantic integration service (SIS) contains 
information models (i.e. database schemas of the data sources 
such as eHOP or SNIIR-AM) as well as semantic resources 
either used in the sources or required for semantic integration 
(reference or interface terminologies, ontologies and mappings) 
and ensures standards' interoperability (such as HL7, PN13, 
HPRIM). SIS provides tools and methods to the other standard 
components.  
Data preprocessing service is devoted to data enrichment. It 
includes NLP tasks and data indexing to make easier extraction 
of useful information from large-scale data stored across the 
different INSAHRE sources. A core functionality of these 
services is to execute data processing tasks and to query the data 
virtualization layer in order to access stored data. The 
developed engine is also responsible for the planning, 
coordination and execution of queries to the data virtualization 
layer in a distributed manner commercial data processing 
frameworks and parallel relational database management 
systems.  
Aggregate computing service is designed for building online 
auxiliary indexing and summarization structures based on the 
incoming data processing tasks and their data requirements. 
Based on profiling and statistic information of the submitted 
processing tasks. For instance this service is used to compute 
from CPOE data, aggregates of drug dose per day, week, stay 
or globally for a patient or a population.  
Data quality and integrity monitoring: The INSHARE 
platform deals with data sources having heterogeneous data 
quality, from EHRs to epidemiologic registries. Integration 
process has thus to manage such quality disparities. This 
component is dedicated to compute metrics to monitor data 
quality during the integration process. These metrics are useful 
(i) to alert data providers and to take corrective actions at the 
data source, (ii) to perform more accurate analysis taken into 
account possible bias due to data quality issues, (iii) to improve 
data quality within the INSHARE platform, each source 
bringing complementary information. For instance, for a same 
patient, in and out hospital drug information come from 
different sources and are registered in different ways (structured 
and coded data from CPOE or SNIIR-AM, text for clinical 
charts, forms and notes). One source can provide more accurate 
or exhaustive information to the others.  
Id Linking service: For security reasons, in France, as in most 
countries, there are currently no patient identifiers that can be 
used to directly link data from different data sources. 
Nonetheless, several national programs or initiatives provide 
researchers either trusted third-party linkage services, or big, 
pre-linked datasets. This, for instance, is the case of the French 
hospital discharge database (used as part of the hospital billing 
system) that matches data coming from all hospitals in France. 
The SNIIR-AM is arguably one of the most noteworthy linked 
data sources recently opened to the research community. The Id 
Linking service reuse and provide methods to link the data 
sources using deterministic and probabilistic approaches on 
common data elements. For instance DRG data coming from 
hospital are already linked with the other data of the SNIIR-
AM. EHOP CDW includes the DRG data. Even without 
specific common Id, linking can be performed using dates, 
groups of diagnosis and procedure codes, and ADT mode.  
Data Governance, study management service and security: 
These services encompass tools, procedures [10]and workflow 
to cover the governance requirements and to provide 
continuous data protection, from their acquisition to their 
outsourcing and mutualization within the INSHARE platform 
and beyond (e.g. when exported). The idea is to complement 
current data protection, which mainly relies on the security of 
the information system and which do not make possible to 
know if data are used for the purposes originally foreseen, 
especially when data are outsourced. The protection of digital 
content we deploy is based on watermarking [8] and crypto-
watermarking solutions (i.e. mechanisms that combine 
encryption and watermarking [11]that fulfill different security 
objectives, in particular in terms of integrity and traceability 
(identification of information-leak sources or of end-user 
misbehavior). If data are protected as long as they are not 
decrypted, watermarking leaves free access to them and 
maintains them protected by means of security attributes (e.g. 
digital signatures, users’ ID, access rights) invisibly inserted or 
embedded into the data themselves. Moreover, watermarking 
protection is independent of the data storage format. These data 
protection tools are designed to take into account strong 
interoperability constraints so as to: i) provide security resilient 
to information-processing; ii) make the protection on the data 
provider’s side compliant with the one used by the INSHARE 
platform and beyond.    
Multisource Query Builder, Visualization and data export 
services: These services are intended to: design and perform 
complex queries on multisource data; visualize results with 
different modalities; and, export processed dataset to the end 
users. From the end user point of view, the interaction with the 
platform consists in submitting a request for a study to the 
platform. Only certified and authorized operators of the 
platform will be able to access to the query workbench for data 
exploitation and eventually to export the required datasets to the 
end user.  
Figure 2 : workflow for ad-hoc study and register enrichement 
Figure 2 and 3 illustrate the workflow for two scenarios. In the 
first one (fig 2), a targeted research database is fed by data 
extracted both from two registries (REIN and Cancer playing 
the role of data provider) according a study protocol about the 
association between kidney failure and occurrence of cancer. 
This protocol, which defines criteria for data selection and 
variables to extract from the source, and user agreement are 
submitted to the platform. Figure 3 illustrates how the platform 
is able to enrich a data source (here the Rein registry) by 
collecting from a list of patient ID, missing or required data 
(e.g. comorbidities) from the different sources. In this scenario 
Rein registry is user of the platform and recipient of data. All 
along this process, health data is maintain secured by means of 
digital content protection tools, with a special interest for data 
traceability and audit trails.   
Figure 3 : workflow for register enrichement 
 
Discussion and conclusion 
The INSHARE project’s consortium made the choice to focus 
on some of today’s crucial challenges, which, in our opinion, 
are still not resolved: data quality assessment for research 
purposes, scalability issues when integrating heterogeneous 
health “big data” or patient data privacy and data protection. 
Moreover, adoption of electronic health data is still an active 
process and the way to exploit these data is rapidly evolving. In 
a second time, the use of health data still requires developing to 
reach maturity: the aforementioned barriers have to be raised 
before we can obtain more significant knowledge and practical 
consequences. In any case, the project’s use-cases were selected 
in view of their potentially important impact on clinical 
knowledge and health research, and we believe they could help 
demonstrate the benefits of secondary use of data. From a 
methodological point of view, our approach goes beyond the 
today’s most cutting-edge secondary-use technologies. We 
propose a combination of innovative algorithms for 
cryptography and watermarking supported by big data 
technologies, with the aim of enhancing content digital 
protection. Compared to other projects mainly oriented to 
distributed architecture, we also follow a different strategy 
based on a trusted third-party oriented on health-data sharing 
within a community of users.  
Lead by the large amount of heterogeneous data available 
among the consortium, traditional approaches for data 
organization and analysis (using classical SQL server such as 
I2B2) are no longer efficient and quite overwhelmed. For 
instance, the Rennes CDW contains by itself raw data of 1.6 
million patients. Recent Big Data technologies are filling the 
gap of this evolution that requires real time analysis, low 
latency, data mining, and heterogeneous unstructured data 
treatment. Born from the needs of scalability, fault tolerance 
and interoperability, challenging frameworks come out as 
Hadoop or Cassandra. However, big data technologies are an 
evolving landscape. The INSHARE project is a great 
opportunity to test and evaluate combination of disruptive 
technologies and provide improved analysis performance in the 
perspective to meet real-world use cases and users needs, on 
real and massive data. For instance, preliminary tests on 
adverse drug effect detection have been carried out. In this 
example, the combination of OrientDB (which is a graph 
oriented database) with SPARK for aggregate computing have 
shown promising performance for intensive computing. 
Nonetheless, applying existent solutions should not be 
sufficient in the background of the Inshare project. Indeed, 
starting from the available massive datasets, a second objective 
aims to design innovative algorithms and techniques in a 
prospective way (using a data sciences approach, sharing the 
statistical and computer sciences skills 
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